PP
ROIV icon

Paloma Partners’s Roivant Sciences ROIV Stock Holding History

Paloma Partners’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-22,037
Closed -$109K – 1655
2022
Q1 		$109K Sell
22,037
-27,963
-56% -$184K ﹤0.01% 1560
2021
Q4 		$504K Buy
+50,000
New +$416K 0.01% 1095

Other funds holding ROIV

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

Paloma Partners's ROIV Position: Q4 2024 in Review

Paloma Partners sold out of Roivant Sciences (ROIV) in Q4 2024, closing a stake of 27,040 shares — an estimated $312K sold.

Paloma Partners first reported a position in ROIV in Q4 2021 and held it in 4 quarters. The position peaked at $312K in Q3 2024. 318 funds tracked by Wall St. Rank hold ROIV as of Q4 2024.

  • Paloma Partners reported no remaining Roivant Sciences position as of Q4 2024 after selling out during the quarter.
  • Paloma Partners sold 27,040 Roivant Sciences shares in Q4 2024, an estimated $312K.
  • Paloma Partners first reported a position in Roivant Sciences in Q4 2021 and held it in 4 quarters.
  • Paloma Partners's Roivant Sciences position peaked at $312K in Q3 2024.
  • 318 funds tracked by Wall St. Rank held Roivant Sciences as of Q4 2024.

Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.